Acknowledgments
Experiments were performed using equipment funded by the Wellcome Trust
(UK) and by the Medical Research Council (UK) New Investigators award
(AB Ali: GO501263) and MRC PhD studentship (MR/N013867/1).
We would like to thank Dr Andrew Constanti (UCL School of Pharmacy) for
his invaluable comments in preparation of this manuscript. We also thank
Miss Audrey Crystalia for assisting in the development and
characterisation of the α2β2γ2-HEK293 stable cell lines, Professor F. A.
Stephenson (UCL School of Pharmacy) for the GABAAR α1
subunit-specific antibody and Professor Jean-Marc Fritschy (University
of Zurich) for the GABAAR α5 and γ2 subunit-specific
antibodies used for the HEK cell lines.